Chemed (CHE) Projected to Post Earnings on Thursday

Chemed (NYSE:CHE) is projected to announce its Q1 2026 results after the market closes on Thursday, April 23rd. Analysts expect Chemed to post earnings of $5.39 per share and revenue of $659.2230 million for the quarter. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Interested persons may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Friday, April 24, 2026 at 10:00 AM ET.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The company had revenue of $639.34 million for the quarter, compared to the consensus estimate of $659.09 million. During the same quarter in the previous year, the business earned $6.83 earnings per share. Chemed’s revenue was down .1% compared to the same quarter last year. On average, analysts expect Chemed to post $22 EPS for the current fiscal year and $25 EPS for the next fiscal year.

Chemed Price Performance

Chemed stock opened at $385.51 on Tuesday. The stock has a market capitalization of $5.63 billion, a PE ratio of 20.99, a price-to-earnings-growth ratio of 1.52 and a beta of 0.49. The business’s fifty day moving average is $409.15 and its 200 day moving average is $427.56. Chemed has a one year low of $365.20 and a one year high of $593.80.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Monday, February 23rd. Chemed’s dividend payout ratio (DPR) is 13.06%.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total value of $806,360.00. Following the completion of the sale, the chief executive officer directly owned 93,719 shares of the company’s stock, valued at approximately $37,785,626.42. This represents a 2.09% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 3.29% of the company’s stock.

Hedge Funds Weigh In On Chemed

Large investors have recently added to or reduced their stakes in the company. Commonwealth Equity Services LLC boosted its position in shares of Chemed by 3.1% in the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after purchasing an additional 22 shares during the period. Cim LLC raised its position in shares of Chemed by 1.1% during the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after purchasing an additional 24 shares during the period. Merit Financial Group LLC lifted its stake in shares of Chemed by 4.0% during the 3rd quarter. Merit Financial Group LLC now owns 940 shares of the company’s stock valued at $421,000 after buying an additional 36 shares in the last quarter. Deutsche Bank AG lifted its stake in shares of Chemed by 1.2% during the 4th quarter. Deutsche Bank AG now owns 2,929 shares of the company’s stock valued at $1,253,000 after buying an additional 36 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its holdings in Chemed by 0.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 5,007 shares of the company’s stock worth $2,242,000 after buying an additional 40 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

CHE has been the topic of a number of recent research reports. Zacks Research downgraded Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $422.00 price objective (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Weiss Ratings lowered shares of Chemed from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, April 13th. Oppenheimer reduced their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Finally, Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $498.00.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.